Influence of FOXP3 single-nucleotide polymorphism after allogeneic hematopoietic stem cell transplantation.
Int J Hematol
; 119(5): 583-591, 2024 May.
Article
em En
| MEDLINE
| ID: mdl-38418747
ABSTRACT
The impact of FOXP3 single-nucleotide polymorphisms (SNP) on clinical outcomes after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains poorly understood. We investigated the relationship between a FOXP3 SNP (rs3761548) and clinical outcomes in 91 patients with hematological malignancies after allo-HSCT. Multivariate analysis showed that risk of severe chronic graft-versus-host disease (cGVHD) was significantly higher in patients with the FOXP3-3279C/A or FOXP3-3279A/A genotype than those with the FOXP3-3279C/C genotype [hazard ratio (HR), 2.69; 95% confidence interval (CI) 1.14-6.31; p = 0.023]. Therefore, FOXP3 at SNP rs3761548 can be a useful marker for predicting the occurrence of severe cGVHD.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transplante Homólogo
/
Transplante de Células-Tronco Hematopoéticas
/
Neoplasias Hematológicas
/
Polimorfismo de Nucleotídeo Único
/
Fatores de Transcrição Forkhead
/
Doença Enxerto-Hospedeiro
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Int J Hematol
Ano de publicação:
2024
Tipo de documento:
Article